SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-095224
Filing Date
2020-08-14
Accepted
2020-08-14 11:32:43
Documents
2
Period of Report
2020-08-04

Document Format Files

Seq Description Document Type Size
1 FORM 3 tm2027438-2_3.html 3  
1 FORM 3 tm2027438-2_3.xml 3 1550
2 EXHIBIT 24.1 tm2027438d2_ex24-1.htm EX-24.1 9939
  Complete submission text file 0001104659-20-095224.txt   13169
Mailing Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016
Business Address 20 COMMERCE DRIVE, SUITE 135 CRANFORD NJ 07016 732-980-4500
ENZON PHARMACEUTICALS, INC. (Issuer) CIK: 0000727510 (see all company filings)

IRS No.: 222372868 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O NEW YORK REIT, INC. 405 PARK AVENUE NEW YORK NY 10022
Business Address
READ RANDOLPH C (Reporting) CIK: 0001074613 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36435 | Film No.: 201103028